Reversing pathological cell states: the road less travelled can extend the therapeutic horizon

Boris N Kholodenko1, Walter Kolch2, Oleksii S Rukhlenko3

  • 1Systems Biology Ireland, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland; Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Dublin, Ireland; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.

PubMed

Insights

Scientists developed cell state transition assessment and regulation (cSTAR) to understand cell networks. This digital twin technology can reverse pathological cell states, like oncogenic transformation, back to normal.

Area of Science:

  • Systems biology
  • Computational biology
  • Genomics

Background:

  • Omics data acquisition is rapidly advancing, but translating this data into actionable control of cell phenotypes and reversal of disease states remains a challenge.
  • Cellular states are governed by complex core networks that influence cell-wide regulatory systems.
  • Understanding the genotype-phenotype connection is crucial for steering cell fate decisions.

Purpose of the Study:

  • To introduce and validate a novel method, cell state transition assessment and regulation (cSTAR), for reconstructing and understanding core cellular networks.
  • To demonstrate the capability of cSTAR models to mechanistically link genotype to phenotype and control cell states.
  • To explore the application of cSTAR in reversing pathological cellular transformations, specifically oncogenic transformation.

Main Methods:

  • Utilizing perturbation biology to quantitatively assess causal relationships within cellular networks.
  • Developing mechanistic models based on cSTAR to represent digital cell twins.
  • Applying cSTAR to model and understand the dynamics of oncogenic transformation.

Main Results:

  • cSTAR successfully quantifies causal connections within cell-wide networks.
  • Mechanistic models derived from cSTAR act as predictive digital cell twins.
  • Demonstrated the potential of cSTAR to guide the conversion of pathological cell states to physiological ones.

Conclusions:

  • cSTAR provides a powerful framework for understanding and manipulating cellular networks.
  • The digital cell twin approach enables targeted interventions to restore normal cell function.
  • cSTAR holds significant promise for therapeutic applications, particularly in reversing oncogenic transformation and other diseases.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K